Posts

Synbiotic Health Welcomes Kevin Hooper as Director of Business Development

Expert in dietary supplement & nutritional product sales will have a key role in commercializing the company’s innovative products.

LINCOLN, Neb. – February 11, 2022 Microbiome-based ingredient company Synbiotic Health announces that Kevin Hooper has joined the company as Director of Business Development. Hooper has more than 14 years’ experience in sales and business development, most recently at the global ingredient supplier IFF Health. At Synbiotic Health he will work with Steve Prescott, Senior Vice President of Business Development, to implement the company’s commercialization strategy for its pipeline of innovative nutritional ingredients.

Hooper has a proven sales record and ability to identify and execute on growth opportunities while maintaining productive relationships across the dietary supplement, food & beverage, and biotechnology industries. His experience spans managing business in raw material/ingredient supply, providing sales and marketing solutions for consumer-packaged goods, and contract manufacturing. Hooper holds a degree from West Virginia University.

“Kevin’s extensive experience with probiotics and fibers will be a great asset to our team as we embark on commercialization of our first two products,” says Prescott.

“We are excited to have Kevin Hooper join our team,” adds Synbiotic Health CEO Tim Brummels. “His professional background and experience will assist us in the advancement of our Ecologically Advanced® probiotics and Synergistic Synbiotic® ingredients in key commercial markets.”


About Synbiotic Health
Synbiotic Health was founded in 2018 by four microbiome research scientists to develop targeted microbiome ingredients to support health. Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics® as well as rationally designed Synergistic Synbiotics®.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health is now commercializing its first two Ecologically Advanced® probiotics: the clinically studied iVS-1® and the laboratory researched iVE-15®. Both of these strains are in additional clinical studies during 2022 to demonstrate the health benefits of these novel ingredients.